Talphera, Inc. (TLPH) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to the Telferra third quarter 2025 financial results conference call. This call is being webcast live via the events page of the investor section of Telferra's website at www.telferra.com. You may listen to a replay of this webcast by going to the investor section of Telferra's website. I would like to turn the call over to Rafi Esedoryan, Telferra's chief financial officer. Please go ahead. Thank you for joining us. on the call today. Today, we announced our third quarter 2025 financial results and associated business updates in a press release. With me today are Vince Angotti, our Chief Executive Officer, and Dr. Shaquille Aslam, Telfaira's Chief Medical Officer. Before we begin, I want to remind listeners that during this call, we will likely make forward-looking statements, within the meaning of the federal securities laws. These forward-looking statements involve risks and uncertainties regarding the operations and future results of Telfera. Please refer to our press release in addition to the company's periodic, current, and annual reports filed with the Securities and Exchange Commission for discussion of the risks associated with such forward-looking statements. These documents can also be found on our website within the investor section. I'll now hand the call over to Vince. Thanks, Rafi. Good afternoon, and thank you to everyone joining our call today. We're excited about the progress made this past quarter, specifically in the continued nephro study enrollment at our current clinical study sites and completing the financing that with the additional tranches provides us sufficient capital to a planned approval of the NIAID PMA later next year. In September, we completed the first closing of $17 million of a two tranche financing, which included core...